Grantham, Mayo, Van Otterloo & Co (GMO)’s Archrock AROC Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio AROC Stock Details AROC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-272,479	Closed	-$2.74M	–	749
2019 Q4	$2.74M	Sell	272,479 -589,500	-68%	-$5.5M	0.02%	355
2019 Q3	$8.59M	Buy	861,979 +244,579	+40%	+$2.44M	0.06%	210
2019 Q2	$6.54M	Buy	617,400 +223,900	+57%	+$2.2M	0.05%	244
2019 Q1	$3.85M	Buy	393,500 +333,200	+553%	+$3.19M	0.03%	310
2018 Q4	$452K	Hold	60,300	–	–	﹤0.01%	451
2018 Q3	$736K	Sell	60,300 -16,500	-21%	-$208K	0.01%	406
2018 Q2	$922K	Buy	76,800 +8,700	+13%	+$96.2K	0.01%	375
2018 Q1	$596K	Hold	68,100	–	–	﹤0.01%	458
2017 Q4	$715K	Buy	+68,100	New	+$739K	﹤0.01%	399

Other funds holding AROC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

HFA

Harvest Fund Advisors Wayne, Pennsylvania $4.87B AUM 49.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s AROC Position: Q1 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Archrock (AROC) in Q1 2020, closing a stake of 272,479 shares — an estimated $2.74M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AROC in Q4 2017 and held it in 9 quarters. The position peaked at $8.59M in Q3 2019. 196 funds tracked by Wall St. Rank hold AROC as of Q1 2020.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Archrock position as of Q1 2020 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 272,479 Archrock shares in Q1 2020, an estimated $2.74M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Archrock in Q4 2017 and held it in 9 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Archrock position peaked at $8.59M in Q3 2019.
196 funds tracked by Wall St. Rank held Archrock as of Q1 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2020, filed 14 May 2020.